6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05312632 (ClinicalTrials.gov)	April 5, 2022	28/3/2022	A Study to Evaluate the Efficacy and Safety of Safinamide Mesilateas Add-on Therapy to Levodopa in P ...	A Multi-center, Open-label Phase 4 Study Evaluating the Efficacy and Safety of Safinamide Mesilateas ...	Parkinson Disease	Drug: Safinamide Mesilate	Eisai Korea Inc.	NULL	Recruiting	19 Years	N/A	All	199	Phase 4	Korea, Republic of
2	JPRN-JapicCTI-153057	14/12/2015	02/11/2015	ME2125 Phase III (ME2125-4)	A Phase III, Long-Term Treatment Study of ME2125 in Patients with Parkinson's Disease with Wearing-O ...	Parkinson's disease	Intervention name : ME2125 (safinamide mesilate) INN of the intervention : safinamide Dosage And admin ...	Meiji Seika Pharma Co., Ltd.	NULL	complete	30		BOTH	200	Phase 3	Japan
3	JPRN-JapicCTI-153056	24/11/2015	02/11/2015	ME2125 Phase II/III (ME2125-3)	A Phase II/III, Double-Blind, Placebo-Controlled Study of ME2125 in Patients with Parkinson's Diseas ...	Parkinson's disease	Intervention name : ME2125 (safinamide mesilate) INN of the intervention : safinamide Dosage And admin ...	Meiji Seika Pharma Co., Ltd.	NULL	complete	30		BOTH	410	Phase 2-3	Japan

First Previous1Next Last